According to Odaily Planet Daily, Nasdaq-listed Solana treasury company Artelo Biosciences announced the issuance of 640,924 shares of common stock to the public at $4.40 per share, raising approximately $3 million in total funds. Artelo Biosciences, a clinical-stage pharmaceutical company, previously announced the official launch of its Solana-based digital asset treasury strategy and invested a portion of its capital in the purchase of SOL tokens. As of now, Artelo holds 45,883 SOL tokens. (uk.investing)